Росія вторглася до України 24 лютого 2022 року. Підтримайте нас у боротьбі за свободу та демократію в Європі.  Підтримайте Україну!  Приєднатися до нас
search
Платформа №1 для лікування за кордоном з 2014 року

S Eroglu

Оториноларинголог

12 років досвіду

Dr. S Eroglu is a medical professional, specializing in several fields, including Septoplasty and Nasal polyp surgery. Dr. Eroglu's professional journey is characterized by involvement in clinical trials and research, especially in targeted therapies and combination immunotherapeutics for melanoma. The doctor has also focused on improving opioid delivery in an inpatient setting and has led a successful Quality Improvement project in this area. Dr. Eroglu has contributed to numerous medical publications.

Місцезнаходження

Дізнайтеся про найвигідніші пакетні пропозиції сезону

clinic image
clinic image clinic image
Натисніть, щоб дізнатися більше про програму
Туреччина, Стамбул
Центр пересадки волосся Клініста (Clinista Hair Clinic)
Ринопластика (пластика носа) "Все включено. Standard"
New clinic
All Inclusive Package

Dr. S Eroglu is a dedicated medical professional, deeply involved in clinical trials, research, and the creation of personalized treatment strategies. The doctor specializes in procedures like Septoplasty and Nasal polyp surgery, among others, and has led successful initiatives to enhance health care delivery systems.

Education

  • Dr. Eroglu earned an MD degree and is board certified in Internal Medicine - Medical Oncology. The doctor completed a residency in Internal Medicine at the University of California, Irvine, and a fellowship in Hematology/Oncology at the City of Hope/Harbor-UCLA Medical Center.

Awards

  • Dr. Eroglu's Quality Improvement (QI) project focused on improving the delivery of opioids in an inpatient setting and was selected as the winning QI project by the American College of Physicians (ACP).

Publications

  • Dr. Eroglu has contributed to diverse publications, with topics encompassing the efficacy of adjuvant radiotherapy in recurrent melanoma after adjuvant immunotherapy and circulating tumor DNA-based molecular residual disease detection for treatment monitoring in advanced melanoma patients.